NOT FOR DISTRIBUTION, PUBLICATION, OR DISCLOSURE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR WITHIN THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA, OR OTHER JURISDICTIONS WHERE SUCH DISTRIBUTION OR PUBLICATION MAY BE UNLAWFUL. ADDITIONAL RESTRICTIONS APPLY. PLEASE REFER TO THE IMPORTANT NOTICES AT THE END OF THIS ANNOUNCEMENT.

Subscription Offer and Further Postponement of the Publication of Annual and Consolidated Financial Statements

Munich, July 01, 2026 – The subscription offer for the cash capital increase resolved by the Executive Board of Cherry SE (ISIN: DE000A3CRRN9) on June 12, 2026, was published in the Federal Gazette and on the Company’s website. The subscription period will begin on July 2, 2026, and close on July 15, 2026, at 12:00 a.m. CEST. In addition to exercising subscription rights, shareholders may submit additional subscription requests through their respective bank (over-subscription right). Shares not subscribed to by shareholders under the subscription or oversubscription rights will be offered to investors for subscription by way of a rump placement.

Due to the ongoing securities-related processing of the capital reduction resolved by the Extraordinary General Meeting on May 22, 2026, the subscription ratio approved by the Executive Board will still be implemented based on the status prior to the capital reduction, i.e., at a ratio of two new shares for every five old shares. The newly issued shares cannot be listed until after the capital increase has been completed, meaning that new shares that have not yet been listed will be credited to the subscribers’ securities accounts.

Further information on the subscription offer is available on the Company’s website at https://ir.cherry.de/en/capitalincrease-2026/.

The Company is updating its estimated publication date of the 2025 Annual Report, to allow sufficient time for the increased coordination and audit efforts associated with the change in auditors and finance personnel. In addition, completion of the audit may be supported by the successful execution of one or more of the following key initiatives – restructuring of the Peripherals division (“Project Blossom”), raising new capital, and sale of one or more of the Company’s divisions. The ongoing bidding process for the Company’s Digital Health & Services division is at an advanced stage. The Company will provide an update on expected timing of publication of the 2025 Annual Report when additional information is available.
 

Important Notes

Not for distribution or publication in the United States of America (including its territories and possessions), Canada, Australia, Japan, South Africa, or any other jurisdiction where such publication may be unlawful. The distribution of this publication may be subject to legal restrictions in certain jurisdictions, and anyone in possession of this document or the information referred to herein should inform themselves of and comply with such restrictions. Failure to comply with such restrictions may constitute a violation of securities laws in such jurisdictions.

This publication is for informational purposes only and does not constitute an offer or a solicitation of an offer to purchase securities of Cherry SE or any of its subsidiaries in the United States of America, Germany, or any other jurisdiction. Neither this publication nor its contents may be relied upon for any offer in any jurisdiction. The aforementioned securities have not been and will not be registered under the Securities Act of 1933, as amended (the “Securities Act”), and may not be sold or offered in the United States of America unless registered or an exemption from the registration requirement under the Securities Act applies.

Outside the Federal Republic of Germany, this publication is directed only at persons who are located in or resident in a member state of the European Economic Area and who are "qualified investors" within the meaning of Article 2(e) of Regulation (EU) 2017/1129.

In the United Kingdom, this notice is directed only at persons who (i) are located outside the United Kingdom, and/or (ii) are qualified investors within the meaning of Article 2(e) of European Regulation (EU) 2017/1129, as transposed into national law by the European Union (Withdrawal) Act 2018, and who also have professional experience in investment matters falling within the definition of “investment professionals” under Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) (the “Regulation”), or persons falling under Article 49(2)(a) to (d) of the Regulation (“high net worth companies, unincorporated associations, etc.”) or falling under any other exemption under the Regulation (whereby all persons under (i) to (ii) are collectively referred to as “Relevant Persons”). Persons who are not Relevant Persons should not act in any way in reliance on this communication or any part of its content. All investments and investment activities referred to in this communication are available only to Relevant Persons and will be conducted only with Relevant Persons.

About Cherry

Cherry SE [ISIN: DE000A3CRRN9] is a global manufacturer of computer input devices such as keyboards, mice, microphones, and headsets for applications in office, gaming, and industry for hybrid work, as well as hardware and software solutions in digital healthcare. Since its founding in 1953, CHERRY has been synonymous with innovative and durable high-quality products, developed in-house, specifically to meet customer needs.

CHERRY’s operational headquarters is in Germany (Auerbach in der Oberpfalz) and it employs staff in development, services, logistics, and production sites in Germany (Auerbach), China (Zhuhai), and Austria (Vienna), as well as in multiple sales offices in Germany (Munich, Auerbach), France (Paris), Sweden (Landskrona), the USA (Kenosha), China (Shanghai) and Taiwan (Taipei).

For more information, visit:https://ir.cherry.de/en/

Contact

Cherry SE
Viona Brandt
Interim Manager Investor Relations
P: Rosental 7, c/o Mindspace, 80331 München
T: +49 (0) 175 93 93 320
E: ir@cherry.de